Study to Evaluate the Pharmacokinetics (Movement of Drugs Within the Body), Safety and Tolerability of Brazikumab in Healthy Chinese and White Participants
Clinical trial NCT05033431 · COMPLETED
Trial details
- NCT number
- NCT05033431
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-11
- Primary completion
- 2022-10-12
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.